Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Tantravahi SK"'
Autor:
Babushok DV; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA., DeZern AE; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD., de Castro CM; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke Cancer Institute, Durham, NC., Rogers ZR; Division of Pediatric Hematology-Oncology, University of Texas, Southwestern Medical Center, Dallas, TX., Beenhouwer D; Partnership for Health Analytic Research, Beverly Hills, CA., Broder MS; Partnership for Health Analytic Research, Beverly Hills, CA., Fanning SR; Prisma Health Cancer Institute, University of South Carolina, Greenville, SC., Gibbs SN; Partnership for Health Analytic Research, Beverly Hills, CA., Hanna R; Department of Pediatric Hematology Oncology and Bone Marrow Transplantation, Cleveland Clinic, Cleveland, OH., Maciejewski JP; Translational Hematology and Oncology Research Department, Cleveland Clinic, Cleveland, OH., Scott BL; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Tantravahi SK; Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Wlodarski MW; Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN., Yermilov I; Partnership for Health Analytic Research, Beverly Hills, CA., Patel BJ; Prisma Health Cancer Institute, University of South Carolina, Greenville, SC.
Publikováno v:
Blood advances [Blood Adv] 2024 Aug 13; Vol. 8 (15), pp. 3946-3960.
Autor:
Vardell VA; Department of Internal Medicine, University of Utah, Salt Lake City, UT; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Ose J; Department of Population Health Sciences, University of Utah, Salt Lake City, UT; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Rets AV; Department of Pathology, University of Utah, Salt Lake City, UT; ARUP Laboratories, University of Utah, Salt Lake City, UT., Tantravahi SK; Department of Internal Medicine, University of Utah, Salt Lake City, UT; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT., Patel AB; Department of Internal Medicine, University of Utah, Salt Lake City, UT; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT. Electronic address: ami.patel@hci.utah.edu.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Jul 31. Date of Electronic Publication: 2024 Jul 31.
Autor:
Vardell VA; Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA., Ermann DA; Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA., Tantravahi SK; Division of Hematology and Hematologic Malignancies, University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah, USA., Haaland B; Department of Population Health Sciences, University of Utah, Salt Lake City, Utah, USA., McClune B; Division of Hematology and Hematologic Malignancies, University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah, USA., Godara A; Division of Hematology and Hematologic Malignancies, University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah, USA., Mohyuddin GR; Division of Hematology and Hematologic Malignancies, University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah, USA., Sborov DW; Division of Hematology and Hematologic Malignancies, University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah, USA.
Publikováno v:
American journal of hematology [Am J Hematol] 2023 Jan; Vol. 98 (1), pp. 41-48. Date of Electronic Publication: 2022 Nov 07.
Autor:
Tantravahi SK; Division of Hematology and Hematologic Malignancies, Huntsman Cancer Hospital, University of Utah, Salt Lake City, Utah, USA., Huber BD; Intermountain Blood & Marrow Transplant/Acute Leukemia Program, LDS Hospital, Salt Lake City, Utah, USA., Vagher J; Division of Hematology and Hematologic Malignancies, Huntsman Cancer Hospital, University of Utah, Salt Lake City, Utah, USA., Maese L; Division of Pediatric Hematology and Oncology, Primary Children's Hospital, Salt Lake City, Utah, USA., Pomicter AD; Hematology Biobank, Huntsman Center of Excellence in Hematologic Malignancies and Hematology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA., Al-Sweel N; Department of Pathology, University of Utah Health, Salt Lake City, Utah, USA.; ARUP Laboratories, Salt Lake City, Utah, USA., Asch JD; Intermountain Blood & Marrow Transplant/Acute Leukemia Program, LDS Hospital, Salt Lake City, Utah, USA., Toydemir RM; Department of Pathology, University of Utah Health, Salt Lake City, Utah, USA.; ARUP Laboratories, Salt Lake City, Utah, USA., Hong B; Department of Pathology, University of Utah Health, Salt Lake City, Utah, USA.; ARUP Laboratories, Salt Lake City, Utah, USA., Parker C; Division of Hematology and Hematologic Malignancies, Huntsman Cancer Hospital, University of Utah, Salt Lake City, Utah, USA.
Publikováno v:
British journal of haematology [Br J Haematol] 2022 Sep; Vol. 198 (6), pp. e78-e81. Date of Electronic Publication: 2022 Jul 25.
Autor:
Pemmaraju N; Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA., Garcia JS; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Potluri J; AbbVie, North Chicago, IL, USA., Harb JG; AbbVie, North Chicago, IL, USA., Sun Y; AbbVie, North Chicago, IL, USA., Jung P; AbbVie, North Chicago, IL, USA., Qin QQ; AbbVie, North Chicago, IL, USA., Tantravahi SK; Huntsman Cancer Hospital, University of Utah, Salt Lake City, UT, USA., Verstovsek S; Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA., Harrison C; Guy's and St Thomas' NHS Foundation Trust, London, UK. Electronic address: claire.harrison@gstt.nhs.uk.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2022 Jun; Vol. 9 (6), pp. e434-e444. Date of Electronic Publication: 2022 May 13.
Autor:
Harrison CN; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Garcia JS; Dana-Farber Cancer Institute, Boston, MA., Somervaille TCP; The Christie NHS Foundation Trust, Manchester, United Kingdom.; Cancer Research UK Manchester Institute, The University of Manchester, Manchester, United Kingdom., Foran JM; Mayo Clinic, Jacksonville, FL., Verstovsek S; The University of Texas MD Anderson Cancer Center, Houston, TX., Jamieson C; University of California San Diego Moores Cancer Center, La Jolla, CA., Mesa R; University of Texas Health San Antonio, San Antonio, TX., Ritchie EK; Division of Hematology and Oncology, Weill Cornell Medical College, New York, NY., Tantravahi SK; University of Utah and Huntsman Cancer Institute, Salt Lake City, UT., Vachhani P; O'Neal Comprehensive Cancer Center at UAB, Birmingham, AL., O'Connell CL; University of Southern California Keck School of Medicine, Los Angeles, CA., Komrokji RS; Moffitt Cancer Center, Tampa, FL., Harb J; AbbVie Inc, North Chicago, IL., Hutti JE; AbbVie Inc, North Chicago, IL., Holes L; AbbVie Inc, North Chicago, IL., Masud AA; AbbVie Inc, North Chicago, IL., Nuthalapati S; AbbVie Inc, North Chicago, IL., Potluri J; AbbVie Inc, North Chicago, IL., Pemmaraju N; The University of Texas MD Anderson Cancer Center, Houston, TX.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 May 20; Vol. 40 (15), pp. 1671-1680. Date of Electronic Publication: 2022 Feb 18.
Autor:
Li P; Division of Hematopathology, Department of Pathology, University of Utah Health, Salt Lake City, UT.; ARUP Laboratories, Salt Lake City, UT., Venkatachalam S; Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; and., Ospina Cordona D; National Human Genome Research Institute, Bethesda, MD., Wilson L; National Human Genome Research Institute, Bethesda, MD., Kovacsovics T; Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; and., Moser KA; Division of Hematopathology, Department of Pathology, University of Utah Health, Salt Lake City, UT.; ARUP Laboratories, Salt Lake City, UT., Miles RR; Division of Hematopathology, Department of Pathology, University of Utah Health, Salt Lake City, UT.; ARUP Laboratories, Salt Lake City, UT., Beck DB; National Human Genome Research Institute, Bethesda, MD., George T; Division of Hematopathology, Department of Pathology, University of Utah Health, Salt Lake City, UT.; ARUP Laboratories, Salt Lake City, UT., Tantravahi SK; Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; and.
Publikováno v:
Blood advances [Blood Adv] 2022 Jan 25; Vol. 6 (2), pp. 405-409.
Autor:
Go RS; Mayo Clinic Cancer Center., Jacobsen E; Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center., Baiocchi R; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute., Buhtoiarov I; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute Cleveland Clinic Children's Hospital., Butler EB; UT Southwestern Simmons Comprehensive Cancer Center., Campbell PK; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center., Coulter DW; Fred & Pamela Buffett Cancer Center., Diamond E; Memorial Sloan Kettering Cancer Center., Flagg A; Yale Cancer Center/Smilow Cancer Hospital., Goodman AM; UC San Diego Moores Cancer Center., Goyal G; O'Neal Comprehensive Cancer Center at UAB., Gratzinger D; Stanford Cancer Institute., Hendrie PC; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance., Higman M; Roswell Park Comprehensive Cancer Center., Hogarty MD; Abramson Cancer Center at the University of Pennsylvania., Janku F; The University of Texas MD Anderson Cancer Center., Karmali R; Robert H. Lurie Comprehensive Cancer Center of Northwestern University., Morgan D; Vanderbilt-Ingram Cancer Center., Raldow AC; UCLA Jonsson Comprehensive Cancer Center., Stefanovic A; Duke Cancer Institute., Tantravahi SK; Huntsman Cancer Institute at the University of Utah., Walkovich K; University of Michigan Rogel Cancer Center., Zhang L; Moffitt Cancer Center; and., Bergman MA; National Comprehensive Cancer Network., Darlow SD; National Comprehensive Cancer Network.
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2021 Nov; Vol. 19 (11), pp. 1277-1303.
Autor:
Patel AB; Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT, USA.; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Pomicter AD; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Yan D; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Eiring AM; Department of Molecular and Translational Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, TX, USA., Antelope O; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Schumacher JA; ARUP Laboratories, Salt Lake City, UT, USA., Kelley TW; Department of Pathology, University of Utah, Salt Lake City, UT, 84112, USA., Tantravahi SK; Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT, USA.; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Kovacsovics TJ; Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT, USA.; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Shami PJ; Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT, USA.; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., O'Hare T; Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT, USA.; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Deininger MW; Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT, USA. Michael.Deininger@hci.utah.edu.; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. Michael.Deininger@hci.utah.edu.
Publikováno v:
Leukemia [Leukemia] 2020 Nov; Vol. 34 (11), pp. 2981-2991. Date of Electronic Publication: 2020 May 14.
Autor:
Atanackovic D; Multiple Myeloma Program, Hematology and Hematologic Malignancies, University of Utah/Huntsman Cancer Institute, Salt Lake City, UT, USA. djordje.atanackovic@hci.utah.edu., Yousef S; Multiple Myeloma Program, Hematology and Hematologic Malignancies, University of Utah/Huntsman Cancer Institute, Salt Lake City, UT, USA.; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Shorter C; Multiple Myeloma Program, Hematology and Hematologic Malignancies, University of Utah/Huntsman Cancer Institute, Salt Lake City, UT, USA., Tantravahi SK; Multiple Myeloma Program, Hematology and Hematologic Malignancies, University of Utah/Huntsman Cancer Institute, Salt Lake City, UT, USA., Steinbach M; Multiple Myeloma Program, Hematology and Hematologic Malignancies, University of Utah/Huntsman Cancer Institute, Salt Lake City, UT, USA., Iglesias F; Pediatric Oncology and Hematology, University of Utah, Salt Lake City, UT, USA., Sborov D; Multiple Myeloma Program, Hematology and Hematologic Malignancies, University of Utah/Huntsman Cancer Institute, Salt Lake City, UT, USA., Radhakrishnan SV; Multiple Myeloma Program, Hematology and Hematologic Malignancies, University of Utah/Huntsman Cancer Institute, Salt Lake City, UT, USA., Chiron M; Sanofi, Vitry-sur-Seine, Paris, France., Miles R; Department of Pathology, University of Utah, Salt Lake City, UT, USA., Salama M; Department of Pathology, University of Utah, Salt Lake City, UT, USA., Kröger N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Luetkens T; Multiple Myeloma Program, Hematology and Hematologic Malignancies, University of Utah/Huntsman Cancer Institute, Salt Lake City, UT, USA.
Publikováno v:
Leukemia [Leukemia] 2020 Jan; Vol. 34 (1), pp. 317-321. Date of Electronic Publication: 2019 Aug 13.